Detalhe da pesquisa
1.
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.
Mov Disord;
26(2): 209-15, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20960474
2.
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Headache;
51(9): 1358-73, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21883197
3.
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
Arch Ophthalmol;
120(10): 1286-93, 2002 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12365906
4.
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Surv Ophthalmol;
49 Suppl 1: S26-35, 2004 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15016559
5.
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
Surv Ophthalmol;
49 Suppl 1: S45-52, 2004 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15016561
6.
Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity.
PM R;
4(1): 4-10, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22200567
7.
Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials.
Clin Ophthalmol;
5: 759-65, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21691584
8.
A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
Pain Med;
8(6): 478-85, 2007 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17716321
9.
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Headache;
47(4): 486-99, 2007 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17445098